- Home
- CDNA vs LTBR Comparison
CDNA vs LTBR Comparison
Compare CDNA & LTBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- LTBR
- Stock Information
- Founded
- CDNA 1998
- LTBR 1992
- Country
- CDNA United States
- LTBR United States
- Employees
- CDNA N/A
- LTBR N/A
- Industry
- CDNA Medical Specialities
- LTBR Professional Services
- Sector
- CDNA Health Care
- LTBR Consumer Discretionary
- Exchange
- CDNA Nasdaq
- LTBR Nasdaq
- Market Cap
- CDNA 712.2M
- LTBR 788.1M
- IPO Year
- CDNA 2014
- LTBR N/A
- Fundamental
- Price
- CDNA $14.50
- LTBR $23.12
- Analyst Decision
- CDNA Buy
- LTBR
- Analyst Count
- CDNA 8
- LTBR 0
- Target Price
- CDNA $26.86
- LTBR N/A
- AVG Volume (30 Days)
- CDNA 951.2K
- LTBR 2.3M
- Earning Date
- CDNA 11-04-2025
- LTBR 11-05-2025
- Dividend Yield
- CDNA N/A
- LTBR N/A
- EPS Growth
- CDNA N/A
- LTBR N/A
- EPS
- CDNA 1.00
- LTBR N/A
- Revenue
- CDNA $340,826,000.00
- LTBR N/A
- Revenue This Year
- CDNA $12.73
- LTBR N/A
- Revenue Next Year
- CDNA $11.90
- LTBR N/A
- P/E Ratio
- CDNA $14.81
- LTBR N/A
- Revenue Growth
- CDNA 14.72
- LTBR N/A
- 52 Week Low
- CDNA $10.96
- LTBR $4.37
- 52 Week High
- CDNA $26.37
- LTBR $31.34
- Technical
- Relative Strength Index (RSI)
- CDNA 48.78
- LTBR 49.36
- Support Level
- CDNA $14.23
- LTBR $23.54
- Resistance Level
- CDNA $15.29
- LTBR $28.44
- Average True Range (ATR)
- CDNA 0.63
- LTBR 2.91
- MACD
- CDNA -0.05
- LTBR -0.29
- Stochastic Oscillator
- CDNA 31.72
- LTBR 26.10
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About LTBR Lightbridge Corporation
Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.